KC21 Peptide Inhibits Angiogenesis and Attenuates Hypoxia-Induced Retinopathy
In conclusion, KC21 peptide is an angiogenic inhibitor potentially useful for treating angiogenesis-related diseases.
Source: Journal of Cardiovascular Translational Research - Category: Cardiology Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Epithelial Cancer | Heart | Study | Vitamin A